欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0853/004
药品名称
Carveratio
活性成分
carvedilol 25.0 mg
剂型
Tablet
上市许可持有人
ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Portugal (PT)
Austria (AT)
Carvedilol-ratiopharm 25 mg Filmtabletten
Spain (ES)
Finland (FI)
Poland (PL)
Carvedilol-ratiopharm
Germany (DE)
许可日期
2008/10/09
最近更新日期
2024/04/18
药物ATC编码
C07AG02 carvedilol
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
IS_H_0308_001_003_IB_006_LAB_Clean_Carvedilol_Alvogen_14_3_2022
Date of last change:2022/06/02
Final PL
|
IS_H_0308_001_003_IB_006_PIL_Clean_Carvedilol_Alvogen_14_3_2022
Date of last change:2022/06/02
Final SPC
|
IS_H_0308_001_003_IB_006_SmPC_Clean_Carvedilol_Alvogen_14_3_2022
Date of last change:2022/06/02
Final PL
|
SE/H/0853/004_Final PL
Date of last change:2014/01/15
Final SPC
|
SE/H/0853/004_Final SPC
Date of last change:2014/01/15
PAR
|
SE/H/0853/004_PAR
Date of last change:2014/01/15
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase